PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
Recruiting now · Phase 3
Conditions studied: Frontotemporal Lobar Degeneration, Alzheimer Disease, Cognitively Normal
In brief
The investigators will compare \[18F\]-PI-2620 tau PET scans from patients with frontotemporal lobar degeneration (FTLD), patients with non-amnestic presentations of Alzheimer's disease (naAD), and demographically matched cognitively normal subjects.
Key facts
- Study ID
- NCT05456503
- Run by
- University of Pennsylvania
- People needed
- 72
- Starts
- 2022-09-19
- Expected to finish
- 2028-08-01
- Last updated by the study team
- 2025-11-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Perelman Center for Advance Medicine — Philadelphia, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.